Primary Site >> Biliary tract Cancer
Gene >> PPARA
| 1. | |||||||||||
| Journal: | Dig Dis Sci. 2006 Sep;51(9):1650-7. | ||||||||||
| Title: | A Ligand for peroxisome proliferator-activated receptor gamma inhibits human cholangiocarcinoma cell growth: potential molecular targeting strategy for cholangioma. | ||||||||||
| Author: | Kobuke, T|Tazuma, S|Hyogo, H|Chayama, K | ||||||||||
| PMID: | 16927143 | ||||||||||
| 2. | |||||||||||
| Journal: | Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Sep;37(5):745-9. | ||||||||||
| Title: | [Expression of PPAR-gamma in human hilar bile duct carcinoma cell line QBC939 and the effects of PPAR-Y activated by its ligand on the growth of QBC939]. | ||||||||||
| Author: | Cheng, Wen|Cheng, Nan-sheng|Xiong, Xian-ze|Xia, Qing-jie|Chen, Oing-ying|Yan, Nai-hong|Jing, Jing | ||||||||||
| PMID: | 17037742 | ||||||||||
| 3. | |||||||||||
| Journal: | J Biol Chem. 2013 Jul 5;288(27):19484-502. | ||||||||||
| Title: | 15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-gamma, SMAD2/3, and TAP63 proteins. | ||||||||||
| Author: | Lu, Dongdong|Han, Chang|Wu, Tong | ||||||||||
| PMID: | 23687300 | ||||||||||
| 4. | |||||||||||
| Journal: | Oncotarget. 2017 Apr 18;8(16):26591-26599. | ||||||||||
| Title: | Genome-wide analysis of long noncoding RNA and mRNA co-expression profile in intrahepatic cholangiocarcinoma tissue by RNA sequencing. | ||||||||||
| Author: | Yang, Wenhui|Li, Yuan|Song, Xia|Xu, Jun|Xie, Jun | ||||||||||
| PMID: | 28427159 | ||||||||||